FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Thursday, Dec. 17, 2020, a panel of independent experts is meeting to discuss a vaccine made by Moderna. The panel's review for the Food and Drug Administration is the next-to-last step before the agency decides whether the shots can be used on an emergency basis. (AP Photo/Hans Pennink)

2nd COVID-19 vaccine set for OK in US with panel endorsement

2nd COVID-19 vaccine set for OK in US with panel endorsement

WASHINGTON — A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.

The Food and Drug Administration is expected to follow the recommendation and quickly OK the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.

Once emergency use authorization is granted, Moderna will begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.

The campaign kicked off earlier this week with the first vaccine OK’d in the U.S., developed by Pfizer and BioNTech. Moderna’s shot showed similarly strong effectiveness, providing 94% protection against COVID-19 in the company’s ongoing study of 30,000 people.

After eight hours of discussion over technical details of the company’s study and follow-up plans, nearly all panelists backed making the vaccine available to help fight the pandemic. One panel member abstained.

“The evidence that has been studied in great detail on this vaccine highly outweighs any of the issues we’ve seen,” said Dr. Hayley Gans of Stanford University Medical Center.

A second vaccine is urgently needed as coronavirus infections, hospitalizations and deaths climb to new highs ahead of the holidays. The U.S. leads the world in virus totals, with more than 1.6 million confirmed cases and more than 310,000 reported deaths.

Moderna’s vaccine uses the same groundbreaking technology as Pfizer-BioNTech’s shot. Most traditional vaccines use dead or weakened virus, but both of the new vaccines use snippets of COVID-19’s genetic code to train the immune system to detect and fight the virus. Both require two doses; Moderna’s is four weeks apart.

The two new vaccines will hopefully help “break the back of the pandemic,” said Dr. Arnold Monto of the University of Michigan, who chaired the panel.

Thursday’s review came days after reports of apparent allergic reactions to the Pfizer-BioNTech vaccine in two Alaska health workers. One person had a severe reaction, including shortness of breath, the other had less serious side effects, including lightheadedness.

While the two vaccines use the same technology, they’re not identical, cautioned Moderna chief medical officer Dr. Tal Zaks. In particular, some of the lipids, or fats, used to coat the two vaccines are different.

“I would not necessarily assume” that any reactions would be the same, he said.

The FDA found no severe allergic reactions in Moderna’s data but flagged a slightly higher rate of less serious side effects — rash, hives, itching — among participants who got the vaccine, compared with those receiving a dummy shot.

There were also three cases of Bell’s palsy, which temporarily paralyzes facial muscles, among vaccine recipients, compared with just one among those getting a dummy shot. The FDA review said the role of the shot in the vaccine group “cannot be ruled out.”

An unanswered question is whether the vaccine also prevents people from symptomless infection — but Moderna found a hint that it may. Study participants had their noses swabbed prior to the second dose of either vaccine or placebo. At that one timepoint, swabs from 14 vaccine recipients and 38 placebo recipients showed evidence of asymptomatic infection, said Moderna’s Dr. Jacqueline Miller.

Moderna is just starting to study its vaccine in children ages 12 to 17. Testing in younger children is expected to start early next year.

After the FDA acts, U.S. officials plan to move out an initial shipment of nearly 6 million Moderna doses. The vaccine needs to be stored at regular freezer temperatures, but not the ultra-cold required for Pfizer-BioNTech’s shot.

With the addition of Moderna’s vaccine, government officials project that 20 million Americans will be able to get their first shots by the end of December and 30 million more in January.

Hundreds of millions of additional shots will be needed to eventually vaccinate the general public, which isn’t expected until the spring or summer. The government’s Operation Warp Speed program has orders for 200 million doses of Moderna’s vaccine. That’s on top of 100 million doses of the Pfizer-BioNTech vaccine. Officials are negotiating to purchase more doses of that vaccine and there are more vaccines in the pipeline.

Like the first vaccine, Moderna’s will remain experimental as the company continues a two-year study needed to answer key questions, including how long protection lasts.

One of the trickiest issues panelists debated was how to keep study volunteers who received a dummy shot from dropping out to get the real shot. Their participation is critical in order to have a comparison for long-term safety and effectiveness.

Moderna proposed immediately alerting all those volunteers of their status and offering them the vaccine. The company said more than 25% of its participants are health workers and some are already leaving to get the Pfizer vaccine.

But Dr. Steven Goodman, an invited expert from Stanford University, suggested Moderna adopt Pfizer’s approach. That company plans to gradually vaccinate people in its placebo group based on when they would have normally had access to the vaccine, as priority groups are established.

But most panelists acknowledged it will be hard to keep volunteers from leaving the Moderna study if they have to wait to get a shot.

“The reality may make that too difficult to do,” said Dr. Steven Pergam of the Seattle Cancer Care Alliance.

Exactly how to treat the trial participants who got dummy shots is important beyond the ethics: Moderna noted that the only COVID-19 death among the 30,000 volunteers was in a placebo recipient, a 54-year-old man whose only risk factor was diabetes.

Knowing there could be more severe coronavirus in placebo recipients as the pandemic continues “weighs heavily on me,” said Moderna’s Miller.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Matthew Perrone And Lauran Neergaard, The Associated Press

vaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

(Contributed)
Red Deer youth missing

Red Deer RCMP seek public’s assistance

Prime Minister Justin Trudeau holds a press conference in Ottawa on Tuesday, May 11, 2021. Trudeau is rejecting accusations from Alberta’s justice minister that his federal government is part of a trio rooting for that province’s health system to collapse due to COVID-19. THE CANADIAN PRESS/Sean Kilpatrick
Alberta justice minister sorry for saying feds, others rooting for COVID disaster

Blame and responsibility have recently been at the centre of debate in Alberta

A rodeo south of Bowden drew a huge crowd on May 1 and 2, 2021. (Photo courtesy Northcott Rodeo Inc. Facebook page)
Alberta takes legal action against pastor, rodeo organizers for gatherings

Rallies and protests have been occurring regularly in Alberta

Minister of Health Patty Hajdu responds to a question during question period in the House of Commons on Parliament Hill in Ottawa on Thursday, Nov. 26, 2020. THE CANADIAN PRESS/Sean Kilpatrick
Coalition says users were shut out of drug decriminalization proposal, demands redo

Health Canada is working on Vancouver request for exemption from criminal provisions on simple possession

Alberta Premier Jason Kenney. THE CANADIAN PRESS/Jason Franson
Here is a list of latest COVID-19 restrictions in effect in Alberta

New mandatory health restrictions are now in effect in Alberta. Additional restrictions… Continue reading

Tampa Bay Lightning goaltender Andrei Vasilevskiy (88) celebrates with defenseman Victor Hedman (77) after the team defeated the Dallas Stars during an NHL hockey game Wednesday, May 5, 2021, in Tampa, Fla. (AP Photo/Chris O’Meara)
Analysis: McDavid NHL’s MVP front-runner in condensed season

Edmonton Oilers captain Connor McDavid has 100-plus point season

Toronto Maple Leafs goaltender Jack Campbell (36) makes a save as Maple Leafs defenceman TJ Brodie (78) and Montreal Canadiens forward Tyler Toffoli (73) look for the rebound during first period NHL hockey action in Toronto on Saturday, May 8, 2021. The Leafs and the Canadiens will meet in the playoffs for the first time in 42 years when the 2020-21 NHL post-season gets underway.THE CANADIAN PRESS/Nathan Denette
Singer Celine Dion performs during her first World Tour show called Courage Wednesday, September 18, 2019 at the Videotron Centre in Quebec City. THE CANADIAN PRESS/Jacques Boissinot
Songbird Uncaged: Celine Dion readies return to Las Vegas stage for 10-date run

Starting on Nov. 5, Dion will play 10 dates at the Resorts World Las Vegas theatre

An Empire Day/Victoria Day gathering of school children on Ross Street by the Cenotaph in the 1920s. On the right hand side, are members of the Red Deer Citizens Band (forerunner of the Red Deer Royals). (Photo via Red Deer Archives)
Victoria Day event helped after war

One hundred years ago, on May 24, 1921, a major community event… Continue reading

Gwynne Dyer
Gwynne Dyer: Independence is a one-way gate

Nicola Sturgeon, First Minister of Scotland declared in 2014 that the referendum… Continue reading

Boston Bruins left wing Nick Ritchie (21) and Washington Capitals defenseman Brenden Dillon (4) battle for the puck during the first period of an NHL hockey game, Tuesday, May 11, 2021, in Washington. (AP Photo/Nick Wass)
Raffl’s late goal pushes Capitals past Bruins, 2-1

Raffl’s late goal pushes Capitals past Bruins, 2-1

Chicago Blackhawks left wing Alex DeBrincat (12) celebrates with teammates after scoring a goal during the second period of an NHL hockey game against the Florida Panthers in Chicago, Saturday, May 1, 2021. (AP Photo/Nam Y. Huh)
Toews’ question chases Chicago Blackhawks into offseason

Toews’ question chases Chicago Blackhawks into offseason

Most Read